Skip to main content

Table 5 Efficacy of a single oral dose of Simparica Trio™ and afoxolaner+ milbemycin oxime against natural tick infestations across all species on dogs presented as veterinary patients in Europe

From: Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe

Study dayTreatment groupnLive tick counts% Efficacy
RangeArithmetic mean
− 1 to 0Simparica Trio™1263–1918.4
Afoxolaner + Milbemycin oxime643–2339.0
7 ± 2Simparica Trio™1260–290.596.6
Afoxolaner + Milbemycin oxime640–130.694.4
14 ± 2Simparica Trio™1260–150.494.8
Afoxolaner + Milbemycin oxime640–100.397.6
21 ± 2Simparica Trio™1260–50.198.1
Afoxolaner + Milbemycin oxime640–20.197.8
30 ± 4Simparica Trio™1260–40.198.6
Afoxolaner + Milbemycin oxime640–80.299.4